Tempus and Eric Lefkofsky Lead the Way with Data Enabled Precision Medicine

It is an unfortunate fact of life that nearly 40% of adults in the United States will face a cancer diagnosis in their lifetime. The National Cancer Institute reports that in 2014 there were over 14 million people in the United States living with cancer. This number is expected to increase yearly. But thanks to the advances of companies like Tempus, the outlook for these patients have never been better.

Tempus, co-founded by Eric Lefkofsky, is a leading innovator in the area of data enabled precision medicine. Lefkosky and his wife lived through a cancer scare of their own when she was diagnosed with breast cancer. It was at this time that Eric Lefkofsky learned of the gaps existing in the cancer treatment field in regards to data collection and digital technology. He would learn that despite the large amount of data collected about patients that there had never been an effort at developing a streamlined and effected way to make use of this data. This fact was the catalyst behind the creation of Tempus.

Tempus began operations with the goal of changing the way cancer care is delivered. The company has developed software that successfully analyzes a patient’s clinical and molecular data. In regards to molecular data, Tempus has used recent technological advances to greatly decrease the cost of gathering genomic information through genomic sequencing.

Eric Lefkofsky’s road to becoming co-founder of Tempus is a quite interesting one. A native of Southfield, Michigan, Lefkofsky graduated from the University of Michigan with high honors in 1991. Lefkofsky would go on to earn his juris doctor degree two years later from the University of Michigan Law School. But despite his academic background, Lefkofsky decided to forego a career in law after becoming enamored in the dot.com revolution where he quickly became a power player.

In addition to his work at Tempus, Eric Lefkofsky also serves on the board of directors at Lurie’s Children’s Hospital in Chicago, the Art Institute of Chicago, and is the chairman of the board of trustees Chicago’s Steppenwolf Theatre Company. Lefkofsky has also held teaching positions at DePaul University’s Kellstadt Graduate School of Business and at Northwestern University’s Kellogg school of Management.